Adlai Nortye Ltd. (ANL)
NASDAQ·Healthcare·Biotechnology
$15.82
+4.37%
Mkt Cap $274.57M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$26.00
Range $20.00 – $32.00
Implied Upside
+64.4%
Consensus $26.00 vs current $15.82
NASDAQ·Healthcare·Biotechnology
$15.82
+4.37%
Mkt Cap $274.57M
No recent rating data.
Price Target (4 analysts)
$26.00
Range $20.00 – $32.00
+64.4%
Consensus $26.00 vs current $15.82